Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation - (Tables)

v3.25.0.1
Stock-Based Compensation - (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation Options Activity
The following table summarizes the activity of common stock options for the period from December 31, 2021 through the year ended December 31, 2024:
Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Aggregate Intrinsic Value
(in thousands)
Outstanding at December 31, 2021 1,884,351  $ 6.99  (1)
Exercised (199,970) $ 3.06 
Forfeited (51,860) $ 3.98 
Expired (111,524) $ 11.97 
Outstanding at December 31, 2022 1,520,997  $ 7.24 
Exercised (197,941) $ 2.58 
Forfeited (284,956) $ 3.39 
Expired (328,677) $ 12.36 
Outstanding at December 31, 2023 709,423  $ 7.73 
Exercised (93,962) $ 3.04 
Outstanding at December 31, 2024 615,461  $ 8.44  2.26 $ 1,054 
Exercisable at December 31, 2024 615,461  $ 8.44  2.26 $ 1,054 
(1)On August 4, 2021, the Company’s Board of Directors declared a special cash dividend of $3.20 per share to the stockholders of record as of the close of business on August 12, 2021, using the after tax cash proceeds from the sale of the Performance Chemicals business. This reflects the impact of the reduction in the strike price on all outstanding vested and unvested stock options by $3.20 per share.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table shows the weighted average assumptions for each of the unvested grants:
2024 Grants 2023 Grants 2022 Grants
Weighted average fair value based on Monte Carlo simulation $ 11.64  (1) $ 12.27  $ 8.82 
Expected dividend yield —  % —  % —  %
Risk-free interest rate 4.09  % 3.80  % 1.51  %
Expected volatility 39.45  % 48.82  % 44.51  %
Expected term (in years) 2.95 2.96 2.91
(1)    Relative to the TSR performance measure only.
Schedule of Nonvested Restricted Stock Awards, Restricted Stock Units and Performance Stock Unit Activity
The following table summarizes the activity of restricted stock awards, restricted stock units and performance stock units for the period from December 31, 2021 through the year ended December 31, 2024:
Restricted Stock Awards Restricted Stock Units Performance Stock Units
Number of
Shares
Weighted Average Grant Date Fair Value (per share) Number of
Units
Weighted Average Grant Date Fair Value (per share) Number of
Units
Weighted Average Grant Date Fair Value (per share)
Nonvested as of December 31, 2021 633,724  $ 15.84  (1) 2,507,421  $ 15.68  1,117,555  (1) $ 16.91 
Granted —  $ —  2,779,690  $ 10.28  295,132  $ 8.82 
Vested (84,903) $ 8.83  (1,550,969) $ 15.08  (496,442) $ 15.41 
Forfeited (271,765) $ 15.84  (1,271,424) $ 12.27  (276,713) $ 12.33 
Nonvested as of December 31, 2022 277,056  $ 15.66  2,464,718  $ 11.73  639,532  (1) $ 16.32 
Granted 5,081  $ 9.84  1,195,835  $ 9.84  721,537  $ 12.28 
Vested (5,081) $ 9.84  (1,436,301) $ 11.84  (200,204) $ 20.16 
Forfeited (277,056) $ 15.66  (261,424) $ 11.27  (201,648) $ 18.57 
Nonvested as of December 31, 2023 —  $ —  1,962,828  $ 10.55  959,217  (1) $ 11.84 
Granted 4,540  $ 8.81  1,126,166  $ 8.84  535,629  $ 10.23 
Vested (4,540) $ 8.81  (1,000,288) $ 11.10  —  $ — 
Forfeited —  $ —  (111,333) $ 9.27  (141,437) $ 12.82 
Nonvested as of December 31, 2024 —  $ —  1,977,373  $ 9.37  1,353,409  (1) $ 11.10 
(1)    Based on target.